AavantiBio is changing the trajectory of precision genetic medicine. We believe it is possible to bring therapies to patients who live with genetic disorders.
aavantibio.com.
Location: United States, Iowa, Cambridge
Employees: 51-200
Total raised: $107M
Founded date: 2017
Investors 4
| Date | Name | Website |
| - | RA Capital... | racap.com |
| - | Perceptive... | perceptive... |
| 02.11.2022 | Xontogeny | xontogeny.... |
| - | Bain Capit... | baincapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.10.2020 | Series A | $107M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 20.11.2022 | From Fighting Shoplifting To Pioneering Gene Therapies, The ... | When it comes to studying the nation’s shoplifting epidemic, Richelle Ross and Diego Rodriguez have ... | forbes.com... |
| 27.04.2021 | AavantiBio and Catalent Announce Partnership to Support Deve... | Our development team at the University of Maryland BioPark is focused on providing process optimizat... | prweb.com/... |
| 22.10.2020 | AavantiBio Lands $107M Series A | CAMBRIDGE, MA, AavantiBio has raised $107 million in a Series A funding round. >> Click her... | vcnewsdail... |
| 22.10.2020 | AavantiBio Launches with $107M in Series A Financing | AavantiBio, a Cambridge, MA-based gene therapy company, launched with $107M in Series A financing. ... | finsmes.co... |
| 22.10.2020 | AavantiBio Launches with $107 Million Series A Financing | CAMBRIDGE, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- A premier syndicate of life sciences investors i... | citybizlis... |